Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart
Phase of Trial: Phase I
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Insulin aspart (Primary)
- Indications Alzheimer's disease; Mild cognitive impairment
- Focus Therapeutic Use
- Acronyms SNIFF-Quick
- 10 Jun 2017 Biomarkers information updated
- 17 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Jul 2018.
- 17 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2018.